You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 11, November 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human T Lymphotropic Virus Type I—Associated Myelopathy

A Report of 10 Patients Born in the United States

William A. Sheremata, MD; Joseph R. Berger, MD; William J. Harrington, Jr, MD; D. Ram Ayyar, MD; Mark Stafford, MD; Elaine DeFreitas, PhD

Arch Neurol. 1992;49(11):1113-1118.


Abstract

• Human T lymphotropic virus type I (HTLV-I)—associated myelopathy (HAM) (tropical spastic paraparesis/HAM) has rarely been reported in the United States. We present 10 well-documented cases with positive Western immunoblot test results and polymerase chain reactions for HTLV-I. The clinical and laboratory features of these American-born patients resemble those previously reported series of tropical spastic paraparesis and HAM from the Caribbean and japan, but important differences were observed. In our study there were equal numbers of whites and blacks and of men and women. Age at onset was younger than that reported from the Caribbean and Japan. Rate of progression to paraparesis varied but was more rapid than previously reported. Half were transfusion recipients but six had multiple sexual partners, with one regularly interacting with prostitutes and reporting a history of drug abuse. Although more rapid progression was seen in the transfusion recipients, this did not explain the earlier age of onset in this group of patients. The HTLV-I, and the associated myelopathy, are endemic in Florida, suggesting that immigration from, and proximity, to the Caribbean basin are contributing risk factors.



Author Affiliations

From the Departments of Neurology (Drs Sheremata, Berger, Ayyar, and Stafford) and the Center for Blood Disease (Dr Harrington), University of Miami/Jackson (Fla) Memorial Hospital Medical Center, and the Wistar Institute, Philadelphia, Pa (Dr DeFreitas).


Footnotes

Accepted for publication April 27, 1992.

Reprint requests to the Department of Neurology, University of Miami, PO Box 016960, Miami, FL 33101 (Dr Sheremata).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study
Orland et al.
Neurology 2003;61:1588-1594.
ABSTRACT | FULL TEXT  

Spinal Anesthesia in Human T Lymphotropic Virus Type I-Associated Myelopathy
Yuasa et al.
Anesth. Analg. 2001;92:1618-1618.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.